University of Durham   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Durham United States (1832)

Organization Overview

First Clinical Trial
2012
NCT01506986
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

University of Durham

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacterial Infections (Phase 4)

Breast Neoplasms (Phase 3)

Cardiovascular Diseases (Phase 3)

Hemorrhage (Phase 4)

Kidney Diseases (Phase 3)

Malaria (Phase 4)

Renal Insufficiency, Chronic (Phase 3)

Ulcer (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 8